metricas
covid
Buscar en
Vacunas (English Edition)
Toda la web
Inicio Vacunas (English Edition) Measles. Re-emergence on its path to eradication
Journal Information

Statistics

Follow this link to access the full text of the article

Review
Measles. Re-emergence on its path to eradication
Sarampión. Reemergencia en el camino de la erradicación
F.A. Moraga-Llop
Corresponding author
fmoraga@acmcb.es

Corresponding author.
Societat Catalana de Pediatria, Asociación Española de Vacunología, Barcelona, Spain
Read
2
Times
was read the article
0
Total PDF
2
Total HTML
Share statistics
 array:23 [
  "pii" => "S244514602030008X"
  "issn" => "24451460"
  "doi" => "10.1016/j.vacune.2020.05.003"
  "estado" => "S300"
  "fechaPublicacion" => "2020-01-01"
  "aid" => "147"
  "copyrightAnyo" => "2020"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "rev"
  "cita" => "Vacunas. 2020;21:41-9"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S1576988720300078"
      "issn" => "15769887"
      "doi" => "10.1016/j.vacun.2020.04.001"
      "estado" => "S300"
      "fechaPublicacion" => "2020-01-01"
      "aid" => "147"
      "copyright" => "Elsevier España, S.L.U."
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "rev"
      "cita" => "Vacunas. 2020;21:41-9"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:1 [
        "total" => 0
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Revisi&#243;n</span>"
        "titulo" => "Sarampi&#243;n&#46; Reemergencia en el camino de la erradicaci&#243;n"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "41"
            "paginaFinal" => "49"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Measles&#46; Re-emergence on its path to eradication"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0010"
            "etiqueta" => "Figura 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 1416
                "Ancho" => 2500
                "Tamanyo" => 263798
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Sarampi&#243;n&#46; A&#46; Facies sarampionosa &#40;conjuntivitis&#44; rinitis y estomatitis&#41;&#46; B&#46; Exantema maculopapuloso caracter&#237;stico&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "F&#46;A&#46; Moraga-Llop"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "F&#46;A&#46;"
                "apellidos" => "Moraga-Llop"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S244514602030008X"
          "doi" => "10.1016/j.vacune.2020.05.003"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S244514602030008X?idApp=UINPBA00004N"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1576988720300078?idApp=UINPBA00004N"
      "url" => "/15769887/0000002100000001/v2_202007040738/S1576988720300078/v2_202007040738/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2445146020300078"
    "issn" => "24451460"
    "doi" => "10.1016/j.vacune.2020.05.002"
    "estado" => "S300"
    "fechaPublicacion" => "2020-01-01"
    "aid" => "146"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "rev"
    "cita" => "Vacunas. 2020;21:50-6"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>"
      "titulo" => "Compulsory or recommended vaccination&#58; Dimensions from the legal perspective"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "50"
          "paginaFinal" => "56"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Vacunaci&#243;n obligatoria o recomendada&#58; acotaciones desde el Derecho"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "C&#46; Cierco Seira"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "Cierco Seira"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1576988720300066"
        "doi" => "10.1016/j.vacun.2020.03.003"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1576988720300066?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2445146020300078?idApp=UINPBA00004N"
    "url" => "/24451460/0000002100000001/v4_202105130819/S2445146020300078/v4_202105130819/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S2445146020300066"
    "issn" => "24451460"
    "doi" => "10.1016/j.vacune.2020.02.002"
    "estado" => "S300"
    "fechaPublicacion" => "2020-01-01"
    "aid" => "142"
    "copyright" => "GlaxoSmithKline Biologicals S&#46;A&#46;"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "rev"
    "cita" => "Vacunas. 2020;21:23-40"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>"
      "titulo" => "Vaccination with conjugate vaccines against pneumococcal disease&#58; What really matters"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "23"
          "paginaFinal" => "40"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Vacunaci&#243;n frente a la enfermedad neumoc&#243;cica con vacunas conjugadas&#58; &#191;qu&#233; es lo que verdaderamente importa&#63;"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1608
              "Ancho" => 2500
              "Tamanyo" => 382163
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Plain language summary&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46;C&#46;De Moraes, X&#46;M&#46; P&#233;rez Porcuna, J&#46; Nieto-Guevara, A&#46; Eisman, B&#46; Torres, J&#46;L&#46; Gonzalez Redondo, X&#46; Saez-Llorens"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "J&#46;C&#46;De"
              "apellidos" => "Moraes"
            ]
            1 => array:2 [
              "nombre" => "X&#46;M&#46;"
              "apellidos" => "P&#233;rez Porcuna"
            ]
            2 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Nieto-Guevara"
            ]
            3 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Eisman"
            ]
            4 => array:2 [
              "nombre" => "B&#46;"
              "apellidos" => "Torres"
            ]
            5 => array:2 [
              "nombre" => "J&#46;L&#46;"
              "apellidos" => "Gonzalez Redondo"
            ]
            6 => array:2 [
              "nombre" => "X&#46;"
              "apellidos" => "Saez-Llorens"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1576988720300029"
        "doi" => "10.1016/j.vacun.2020.02.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1576988720300029?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2445146020300066?idApp=UINPBA00004N"
    "url" => "/24451460/0000002100000001/v4_202105130819/S2445146020300066/v4_202105130819/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Review</span>"
    "titulo" => "Measles&#46; Re-emergence on its path to eradication"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "41"
        "paginaFinal" => "49"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "F&#46;A&#46; Moraga-Llop"
        "autores" => array:1 [
          0 => array:4 [
            "nombre" => "F&#46;A&#46;"
            "apellidos" => "Moraga-Llop"
            "email" => array:1 [
              0 => "fmoraga@acmcb.es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Societat Catalana de Pediatria&#44; Asociaci&#243;n Espa&#241;ola de Vacunolog&#237;a&#44; Barcelona&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Sarampi&#243;n&#46; Reemergencia en el camino de la erradicaci&#243;n"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig0010"
        "etiqueta" => "Fig&#46; 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 851
            "Ancho" => 1501
            "Tamanyo" => 129734
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0010"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Measles&#46; A&#46; Measles facies &#40;conjunctivitis&#44; rhinitis and stomatitis&#41;&#46; B&#46; Characteristic maculopapular exanthema&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0010" class="elsevierStylePara elsevierViewall">It was 40 years ago now&#44; in 1980&#44; when the World Health Organisation &#40;WHO&#41; certified the eradication of smallpox&#46; After having overcome many obstacles&#44; for some time we have been progressing towards doing the same with poliomyelitis&#46; Two of its causal agents &#40;poliovirus 2 and 3&#41; have now been eradicated&#44; and only type 1&#44; which is endemic in Pakistan and Afghanistan&#44; is still circulating&#46; The WHO had set the objective of eradicating a third disease&#44; measles&#44; by 2020&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Nevertheless&#44; in 2017 this goal was seen to be impossible to achieve because the disease had re-emerged&#44; and in 2019 morbidity worldwide due to this disease tripled&#44; with high rates of mortality&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Measles was the first infectious exanthematous disease to be&#44; classified&#44; in as 1627&#44; Sydenham differentiated it from scarlet fever&#44; they became known as&#44; the first&#44; second disease&#44; respectively&#46; In it was recognised as 1881&#44; different from the third disease&#44; which was designated rubella or German Measles &#40;in honour of the German authors who were interested in studying it&#41;&#46; In and 1885&#124; 1894&#44; Filatow&#40;in honour of the German authors who were interested in studying it&#41;&#44; Dukes described a fourth disease&#44; which was denominated scarlet fever-like rubella&#44; which eventually &#8220;disappeared&#8221; as&#44; such&#44; it consisted of clinically mild forms of scarlet fever&#46; In as 1905&#44; a fifth disease or infectious erythema was defined&#44; in 1910&#44; roseola infantum was mentioned for the first time&#44; as&#44; exanthema subitum or a sixth disease&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> From then on exanthematic diseases ceased to be&#44; given ordinal numbers&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">Before the introduction of widespread vaccination campaigns measles infected from 95&#37;-98&#37; of children under the age of 18 years old&#44; causing approximately 135 million cases and more than 6 million deaths per year worldwide&#44; with mortality rates of approximately 3&#37;-34&#37; in developing countries&#44; from 10 to 20 times higher than the rates in industrialised countries&#46;<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4&#44;5</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The worldwide incidence of measles has now increased&#44; making it necessary to know or recall its clinical signs&#46; This is so above all in the case of doctors who did not become familiar with this disease during their training&#44; as diagnosis must be a suspicion during anamnesis and patient examination&#46; This review analyses the most relevant epidemiological&#44; clinical and diagnostic aspects of measles&#44; together with preventive measures&#46;</p></span><span id="sec1005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect1025">Epidemiology</span><p id="par0030" class="elsevierStylePara elsevierViewall">Measles is a highly contagious disease&#44; with a secondary attack rate close to or above 90&#37;&#46; It is seasonal&#44; and is most common at the end of winter and the beginning of spring&#46; In a susceptible population one case will originate from 12 to 18 secondary cases&#46; This figure is denominated R&#176; or the basic reproduction number&#44; and it is one of the highest in infectiology&#46; As measles is one of the most contagious diseases&#44; immunity levels of 95&#37; or higher are needed in the population to interrupt its transmission and eliminate it from the community&#46;<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6&#8211;9</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">The disease has an exclusively human reservoir&#44; and its mechanism of transmission is direct by person to person contact through Fl&#252;gge droplets &#40;&#62;&#8201;5&#8201;&#181;&#41; of respiratory secretions that are swiftly deposited when coughing&#44; sneezing or talking&#46; This means that transmission is only possible at a distance of somewhat less than 1&#8201;m&#46; It may also be transmitted through the air by aerosols of small droplets &#40;&#60;&#8201;5&#8201;&#181;&#41;&#44; and by direct contact with nasal and pharyngeal secretions&#46; Another less common mechanism is by indirect contact through fomites recently contaminated by nasopharyngeal secretions&#46;<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6&#8211;8</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">The duration of transmittability or contagiousness lasts from one to two days prior to the start of symptoms &#40;4 days prior to the start of the exanthema&#41; until 4 days after the appearance of the eruption&#46; Children may not return to their kindergarten or school until at least 5 days have passed after the start of the exanthema&#44; always on condition that their general state makes this possible&#46; Immunodepressed patients have a longer period of viral secretion&#44; and they may still be contagious for several weeks after the appearance of the exanthema&#46;<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6&#8211;8</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Systematic vaccination has changed the epidemiological pattern&#58; cases are observed in children not vaccinated with 2 doses after one year of age&#44; or when they had not received their first vaccination &#40;failure to receive their second vaccination is very rare&#41;&#46; The global number of cases has now undergone a major increase&#44; and this seriously threatens the possibility of eradication in the next few years&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Although there are several reasons why measles has resurged&#44; they always coincide in the reduction of vaccination coverage&#46; Reluctance to vaccinate predominates in developed countries&#46; This is a broad concept that runs from people who deeply reject all vaccines&#44; to those that accept them with doubts and concerns&#46; It also includes people who belong to certain political&#44; religious&#44; cultural and lifestyle groups&#46; Isolation from the healthcare system may in some cases be decisive in not vaccinating&#46; A range of causes and situations exist in countries that lack economic resources&#58; political&#44; social conflict or war&#44; a shortage of supplies or fear about the safety of vaccination&#46; Other factors that should be considered and studied are the early loss of transplacental immunity in the children of vaccinated mothers&#44;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> the age when the first dose is administered<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;12</span></a> and concordance between the circulating virus genotype and those of the vaccines&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">This situation must not continue&#44; as measles fulfils all of the criteria for eradication&#58; it is an infection which is limited to humans and is transmitted from person to person&#44; there are no chronic carriers&#44; there is a single causal agent&#44; the transmissibility period is short&#44; a safe and effective vaccine is available and natural or vaccinated immunity lasts for a long time&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">If the global situation of measles continues as it is&#44; the WHO should consider declaring this resurgence to be an international public health emergency&#44; so that firstly the disease can be controlled&#44; followed by its eradication&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a></p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Measles in the world</span><p id="par0065" class="elsevierStylePara elsevierViewall">According to WHO data corresponding to December 2019&#44; before the vaccine came into general use in 1963&#44; every 2-3 years there were major epidemics that caused up to 2 million deaths per year&#46; From 2000 to 2016 vaccination against measles reduced the number of deaths by 84&#37;&#44; down from 550&#44;000 to 90&#44;000 individuals&#44; most of them under the age of 5 years old&#46; Nevertheless&#44; this figure rose to 110&#44;000 in 2017 &#40;total incidence&#58; 6&#46;7 million cases&#41; and to 140&#44;000 in 2018&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> It is estimated that during the period from 2000-2018 vaccination against measles prevented 23&#46;2 million deaths worldwide&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> In 2018&#44; 86&#37; of newborn babies received their first vaccine dose before their first birthday&#44; vs&#46; 72&#37; in the year 2000&#44; although only 69&#37; received the second dose&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">The number of cases of measles tripled from 2017 to 2019&#44; although the WHO&#44; taking into account the fragility of monitoring systems in many countries&#44; estimates that this increase is probably up to 10 times greater&#46; Current worldwide mortality is higher than 300 deaths per day&#44; the majority of them younger than 5 years old&#46; This increase in the incidence of measles has varied from one WHO region to another&#44; and Africa stands out with an increase of 900&#37; in 2019 over the previous year&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">Although North and South America were free of measles from 2016&#44; more than 15&#44;000 cases were reported in 2019 in 14 countries&#44; with 18 deaths&#46; Brazil stands out with more than 13&#44;000 cases and 15 deaths&#44; together with the United States with 1&#44;282 cases and Venezuela with more than 500 cases and 2 deaths&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">The largest outbreak in the United States since 1992 occurred from 30 September 2018 to 3 September 2019&#46; There were 654 cases in New York&#44; the majority in Brooklyn and Rockland County&#44; caused by a fall in vaccination rates&#44; most especially in the community of Orthodox Jews&#46; Although measles had been declared to have been eliminated from the United States in the year 2000&#44; there were a total of 1&#44;282 cases in 2019&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">Outbreaks of measles have been reported in many South East Asian and Pacific countries since 2017&#46; An outbreak has been running in the Philippines since the end of 2017&#44; with more than 20&#44;000 cases and 199 deaths in 2018&#46; This outbreak increased notably in 2019&#44; as the population ceased vaccinating due to a loss of trust after the failure and controversies arising from the introduction of a Dengue fever vaccine&#46; An outbreak was declared in the islands of Samoa in October 2019&#46; This affected 5&#44;697 people and caused 83 deaths&#44; and it occurred due to a fall in vaccination coverage because of an error in administering a vaccine that led to the deaths of 2 children&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> Another major outbreak occurred in the Democratic Republic of the Congo in June 2019&#44; simultaneously with an outbreak of Ebola&#44; with more than 250&#44;000 cases and 6&#44;000 deaths&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Measles in Europe</span><p id="par0090" class="elsevierStylePara elsevierViewall">A highly important fact that must be pointed out is that&#44; according to data from the first half of 2019&#44; the WHO withdrew measles elimination certification from 4 countries&#58; the United Kingdom&#44; Greece&#44; Albania and the Czech Republic&#44; because their vaccination programs did not maintain coverage of 95&#37; or more&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> The current situation regarding the elimination of measles in the world is that it has been achieved in 83 &#40;42&#37;&#41; of the 194 WHO member states&#44; and in 70&#37; of the countries in the WHO European region&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">In 2017&#44; several countries in the WHO European Region recorded outbreaks in children and adults&#44; including France&#44; Georgia&#44; Greece&#44; Italy&#44; Rumania&#44; the Russian Federation&#44; Serbia and Ukraine&#46; Since then &#40;as the lowest figure was achieved in 2016&#44; with 5&#44;273 cases&#41; the number of cases has quadrupled &#40;25&#44;863&#44; 88&#44;693 and 101&#44;280 cases in 2017&#44; 2018 and January - October 2019&#44; respectively&#41;&#46; It should be underlined that there were 74 deaths in 2018&#44; vs&#46; 42 in 2017&#46;</p><p id="par0100" class="elsevierStylePara elsevierViewall">The largest outbreak with a death in a decade occurred in Israel in 2018&#46; This affected the Orthodox population of Jerusalem above all due to their refusal to vaccinate&#44; with vaccination rates of 85&#37; that in the schools with the highest rates of morbidity did not attain 50&#37;&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Measles in Spain</span><p id="par0105" class="elsevierStylePara elsevierViewall">On 26 September 2017 the WHO declared Spain free of endemic measles transmission&#44; recognising that the few cases and outbreaks reported in the previous 3 years had been the result of importations &#40;while in Catalonia the disease had been declared to have been eliminated in the year 2000<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a>&#41;&#59; in 2019 the WHO ratified the elimination of measles in our country&#46;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">The number of confirmed cases of measles has risen from a rate of 0&#46;8 cases per million inhabitants in 2015 up to 4&#46;8 in 2018 and approximately 6 &#40;provisional data&#41; in 2019&#46; Of the 287 cases in the past year &#40;vs&#46; 222 in 2018&#41;&#44; 36 were imported&#44; 237 were connected and 14 were of unknown origin&#59; there were no autochthonous cases&#46;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> Of the 157 cases of measles recorded in 2017&#44; 66&#46;9&#37; were in individuals over the age of 19 years old&#44; and all of them were imported or connected with imported cases&#44; of which 86&#37; corresponded to European countries &#40;Rumania&#44; Italy&#44; the United Kingdom and France&#41; while 14&#37; correspond to Asia &#40;China&#44; Indonesia and Japan&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a></p></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Clinical manifestations</span><p id="par0115" class="elsevierStylePara elsevierViewall">Measles is an infectious disease caused by a virus of the <span class="elsevierStyleItalic">Morbillivirus</span> genus of the <span class="elsevierStyleItalic">Paramyxoviridae</span> family&#46; Only one serotype of the measles virus exists&#44; and there are a great many circulating genotypes due to its high genetic variability&#46; It is a very labile virus&#44; and it is vulnerable to external agents such as light and heat&#44; which render it inactive&#46; This disease is the first of the long list of maculopapular exanthemas&#44; and it gave the name of &#8220;morbiliform&#8221; exanthemas to cutaneous eruptions with different aetiologies with morphological characteristics similar to those of measles&#46;</p><p id="par0120" class="elsevierStylePara elsevierViewall">Measles has highly uniform clinical manifestations &#40;<a class="elsevierStyleCrossRefs" href="#fig0005">Figs&#46; 1 and 2</a>&#41;&#44; and 4 periods after contagion are distinguished in its evolution&#58;<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1</span><p id="par0125" class="elsevierStylePara elsevierViewall">The incubation period&#58; this runs from the moment of exposure to the virus and its penetration in the organism until the start of prodromic or catarrhal symptoms&#46; This coincides with the secondary viremia and involvement of the respiratory mucosa&#44; and it lasts for 8-12 days&#46; The time lapse until the moment exanthema commences may be up to 21 days&#44; with an average of 14 days&#46; The duration is longer after the administration of general purpose immunoglobulin&#44; which forms part of the post-exposure prophylaxis or in patients undergoing replacement therapy&#44; in breast-feeding babies due to the persistence of maternal antibodies&#44; and in immunodeficient individuals&#46; This period may be shortened in exceptional cases&#44; such as direct infection of a cutaneous wound with infected secretions&#44; or parenteral infection&#46; This is an asymptomatic period&#44; except for fleeting temperature variations&#44; slight discomfort or mild respiratory symptoms that are almost always hard to notice and detect&#46;</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2</span><p id="par0130" class="elsevierStylePara elsevierViewall">The prodromic&#44; catarrhal or pre-exanthematic period&#58; this lasts for an average of 4 days&#44; although not uncommonly it may last longer&#44; up to 10 days&#46; As is the case during the exanthematic period&#44; the symptoms may vary or attenuate due to the previous administration of immunoglobulin or vaccine&#46; Prodromes are manifested by constant high fever which may sometimes give rise to feverish convulsions&#44; cephalea&#44; somnolence&#44; general discomfort and catarrhal symptoms due to involvement of the conjunctival&#44; nasal and oropharyngeal mucosa and that in the upper airways &#40;the larynx and trachea&#41;&#46; Ocular&#44; nasal and oral alterations&#44; with a certain degree of facial swelling&#44; configure the characteristic measles facies&#46; The oral exanthema &#40;Koplik spots&#41; was described by Flindt in 1860&#59; Koplik described their pathognomic nature in 1896&#44; and Rembold and Flindt published this observation in 1905&#46; They consist of small pointed raised spots&#44; white in colour &#40;&#8220;like salt spots&#8221;&#41;&#44; surrounded by a reddish halo or an erythematous base&#46; They occur in the jugular mucosa and on the internal face of the cheeks opposite to the molars in 70&#37;-90&#37; of cases&#46; They appear at the end of the prodromic period immediately before the exanthema &#40;1-2 days&#41;&#44; and they disappear within 24-48&#8201;hours of the start of the latter&#46; The exanthema makes it possible to diagnose measles prior to the appearance of the characteristic exanthema&#46; Similar spots to Koplik spots may appear on the mucosa of the lips&#44; eyelid&#44; conjunctiva&#44; nose and vagina&#44; as well as on the outer wall of the pharynx&#44; although these locations are rarely involved&#46;</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3</span><p id="par0135" class="elsevierStylePara elsevierViewall">The period corresponding to the condition or exanthematic period&#58; fever rises when the cutaneous eruption starts&#44; when catarrhal eye-nose-pharynx-larynx-trachea-bronchial symptoms and general involvement are at their most intense&#44; while the Koplik spots disappear&#46; This period lasts from 3 to 5 days &#40;up to 7 days&#41;&#44; during which the symptoms evolve&#46; The exanthema is maculopapular&#44; violet red in colour and very numerous&#44; not confluent at first and generally not pruriginous&#59; it commences in the area behind the ears and spreads over 3 days&#44; descending over the rest of the face and neck&#44; the trunk and limbs&#44; without involving the palms of the hands or the soles of the feet and converging&#46; If the fever increases or reappears then a complication of the measles must be suspected&#46;</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">4</span><p id="par0140" class="elsevierStylePara elsevierViewall">The convalescence&#44; decline or desquamation period&#58; this starts on the third or fourth day of the exanthematic period&#44; with reduction and disappearance of the fever and catarrhal symptoms except for the cough&#44; which may last for a few days or weeks&#44; and the skin eruption&#44; in the same order in which they arose&#44; together with an important improvement in general condition&#46; The presence of a bran-like small scale desquamation is characteristic of this phase&#44; leaving the skin violet or brown in colour and enabling retrospective diagnosis&#46; The cough and bronchial symptoms are the last to disappear&#46;<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24&#8211;28</span></a></p></li></ul></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0145" class="elsevierStylePara elsevierViewall">Other infections are often present while convalescing from measles &#40;influenza&#44; whooping cough&#44; diphtheria&#44; tuberculosis&#44; parotitis&#44; scarlet fever&#44; varicella and aphthous stomatitis&#41;&#46; This had been observed in the time before vaccination&#44; when measles was described as an anergising disease because the measles virus eliminates antibodies that protect against infections which the body had been immune to&#44; and specific immunity memory cells that had been generated against other diseases&#46; This phenomenon of amnesia or immunity dysfunction against other infectious diseases may still be observed five years after suffering measles&#44; so that anti-measles vaccine may be said to protect against more than measles itself&#44; as it also protects against other infectious diseases&#46;<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">29&#44;30</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Clinical forms</span><p id="par0150" class="elsevierStylePara elsevierViewall">The clinical manifestations of measles may change and have characteristics other than those described&#46; It takes the following clinical forms&#58;<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24&#44;26&#44;31</span></a><ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">-</span><p id="par0155" class="elsevierStylePara elsevierViewall">Abortive or modified measles&#58; the exanthema has fewer elements and colouration is paler&#44; while the symptoms are mild&#59; sometimes this is experienced in a subclinical form&#46; The incubation period is longer&#46; This clinical form occurs after the administration of general purpose immunoglobulin during the incubation period or in the first half of the prodromic period&#44; or after the previous administration of anti-measles vaccine&#46; This form may also be seen in breastfeeding babies due to the persistence of maternal antibodies&#46; These patients may suffer a second clinical infection if conferred immunity is incomplete&#46;</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">-</span><p id="par0160" class="elsevierStylePara elsevierViewall">Attenuated measles&#58; this is an adverse reaction which occurs 5 to 12 days after vaccination&#46; It develops with little fever and mild catarrhal symptoms&#44; with a pale maculopapular exanthema with few elements&#46;</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">-</span><p id="par0165" class="elsevierStylePara elsevierViewall">Measles without exanthema or without fever&#58; both of these forms are very rare and may occur in one family member during an outbreak&#46; Retrospective diagnosis is by means of specific IgM determination&#44; as the disease does not appear in anamnesis&#46;</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">-</span><p id="par0170" class="elsevierStylePara elsevierViewall">Black and haemorrhagic measles&#58; the exanthema elements undergo a haemorrhagic transformation due to the rupture of the papular capillaries &#40;black form&#41;&#46; This clinical form does not indicate greater severity if there is no haemorrhagic diathesis with cutaneous and mucosal manifestations in other locations&#44; due to thrombocytopenia or more severe disseminated intravascular coagulation &#40;haemorrhagic form&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">-</span><p id="par0175" class="elsevierStylePara elsevierViewall">Vesiculosus or blistering measles&#58; this may appear in children with intense hyperhydrosis in hot humid environments&#46;</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">-</span><p id="par0180" class="elsevierStylePara elsevierViewall">Converging scarlatiniform measles&#58; catarrhal symptoms help to differentiate this from scarlet fever&#46;</p></li><li class="elsevierStyleListItem" id="lsti0055"><span class="elsevierStyleLabel">-</span><p id="par0185" class="elsevierStylePara elsevierViewall">Pseudoappendicular measles&#58; abdominal pains frequently occur in the prodromic and condition periods&#46; They are sometimes intense and located in the right iliac fossa&#44; and this may lead to an appendectomy&#44; in which the existence of mesenteric adenitis is observed&#44; and more rarely true appendicitis&#46;</p></li><li class="elsevierStyleListItem" id="lsti0060"><span class="elsevierStyleLabel">-</span><p id="par0190" class="elsevierStylePara elsevierViewall">Atypical measles&#58; this occurs in individuals immunised with inactivated virus vaccine that was used from 1963 to 1967 in the United States and Canada&#44; and atypical measles occurs when they are subsequently exposed to the wild virus&#46; The disease usually runs in two phases&#44; at first as immunisation-modified measles&#44; followed after 2 weeks by high fever and atypical exanthema&#46; The latter spreads centripetally and involves the hands and feet&#44; and it is occasionally vesiculosus and purpuric&#46; Pulmonary complications are common&#44; with hilar adenopathies&#44; pleural bleeding and diffuse nodular infiltrates&#46; This is considered to be an immunocomplex-delayed hypersensitivity phenomenon&#46;<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a></p></li><li class="elsevierStyleListItem" id="lsti0065"><span class="elsevierStyleLabel">-</span><p id="par0195" class="elsevierStylePara elsevierViewall">Adult measles&#58; this clinical form is more severe than measles in childhood and it has more complications&#44; chiefly pneumonia&#44; bacterial respiratory infections&#44; bronchospasm and hepatitis&#46;</p></li><li class="elsevierStyleListItem" id="lsti0070"><span class="elsevierStyleLabel">-</span><p id="par0200" class="elsevierStylePara elsevierViewall">Severe measles in patients with cellular immunity disorders&#58; this may develop without exanthema and it frequently leads to complications&#44; among which progressive acute encephalitis with measles inclusion bodies stands out&#44; together with giant cell pneumonia&#46;</p></li><li class="elsevierStyleListItem" id="lsti0075"><span class="elsevierStyleLabel">-</span><p id="par0205" class="elsevierStylePara elsevierViewall">Measles during pregnancy&#58; the most important effect of the virus on the mother is that it increases her risk of suffering complications&#44; most especially respiratory ones &#40;pneumonitis&#41;&#44; and for the foetus&#44; as it may cause an abortion or premature birth&#46; The measles virus has not been proven to have teratogenic effects&#46;</p></li></ul></p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Complications</span><p id="par0210" class="elsevierStylePara elsevierViewall">The most important and frequent complications of measles are respiratory and neurological&#44; and they almost always occur during or after the exanthematic period&#46; In general&#44; complications with measles should always be suspected when the fever persists or reappears&#46; The most common complications are acute otitis media&#44; diarrhoea&#44; mastoiditis&#44; sinusitis&#44; cervical lymphadenitis&#44; stenosing laryngitis&#44; laryngotracheobronchitis&#44; pneumothorax&#44; pneumomediastinum and subcutaneous emphysema&#44; pneumonia or bronchopneumonia &#40;viral&#44; bacterial or mixed&#41;&#44; enteritis&#44; thrombocytopenic purpura&#44; pyodermitis&#44; feverish convulsions&#44; hepatitis&#44; appendicitis&#44; myocarditis and acute post-infectious encephalitis with permanent brain damage &#40;one in every 1&#44;000-2&#44;000 cases of measles&#41;&#46; The most frequent microorganisms in bacterial infections are <span class="elsevierStyleItalic">Streptococcus pneumoniae</span>&#44; <span class="elsevierStyleItalic">Streptococcus pyogenes</span> and <span class="elsevierStyleItalic">Staphylococcus</span> aureus&#46;<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24&#44;26&#44;28</span></a></p><p id="par0215" class="elsevierStylePara elsevierViewall">Subacute sclerosing panencephalitis is a chronic degenerative disease of the central nervous system which develops with behavioural disorders&#44; intellectual deterioration and myoclonic epilepsy&#44; and it is caused by the chronic activation of the measles virus&#46; More than half of patients had been diagnosed with measles in the first 2 years of life&#46; Clinical manifestations commence after an average 7-11&#8201;year period of latency after having had the disease&#46; The risk of subacute sclerosing panencephalitis amounts to 4-11 cases per 100&#44;000 cases of measles&#46;</p><p id="par0220" class="elsevierStylePara elsevierViewall">Death caused by measles is due to respiratory and neurological complications&#44; and the mortality rate is higher in children younger than 5 years old&#44; adults and immunodepressed individuals&#44; including children with leukaemia&#44; individuals with human immunodeficiency virus infection and those with severe malnutrition&#46; Lethality varies from 1&#37; to 15&#37; in developing countries&#46;<a class="elsevierStyleCrossRefs" href="#bib0155"><span class="elsevierStyleSup">31&#44;33</span></a></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Diagnosis</span><p id="par0225" class="elsevierStylePara elsevierViewall">Although diagnosis is based on symptoms and epidemiology&#44; it must always be confirmed in the current stage of resurgence to ensure proper epidemiological vigilance&#46; This has to include the determination of the specific IgM after the fourth day of the appearance of the exanthema &#40;preferentially from day 4 to 8 and before day 28&#41;&#44; or the specific IgG in 2 samples separated by an interval of 2-4 weeks&#59; diagnosis is late in the latter case&#46; Early confirmation of IgM positivity is very important to enable the urgent adoption of preventive measures in contacts and in the social circle of the patient &#40;their home&#44; kindergarten&#44; school&#44; waiting rooms&#44; primary care emergency services and in hospitals&#41;&#46; Another method is the detection of the virus in urine or pharyngeal swab by polymerase chain reaction in the 8 days following the appearance of the exanthema&#46; Genotyping the virus is important for epidemiological vigilance&#44; the study of outbreaks and evaluation of the efficacy of vaccines&#46;<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7&#44;8&#44;34</span></a></p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Actions&#44; preventive measures and treatment</span><p id="par0230" class="elsevierStylePara elsevierViewall">If there is the suspicion of measles in a patient the epidemiological vigilance service must be notified urgently&#44; the specific IgM must be determined and the patient is to be isolated or wear a surgical mask&#46; If the case if confirmed the epidemiological questionnaire will be applied&#44; together with post-exposure prophylaxis for susceptible contacts&#46;<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">34</span></a></p><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Post-exposure prophylaxis</span><p id="par0235" class="elsevierStylePara elsevierViewall">After exposure to the measles virus a susceptible individual will act according to the time that has transpired from the moment of contact&#58;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a><ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0080"><span class="elsevierStyleLabel">-</span><p id="par0240" class="elsevierStylePara elsevierViewall">In the first 72&#8201;hours after contact&#58; vaccination if this is not contraindicated&#46; In babies younger than 6 months old&#44; pregnant women and immunodepressed patients&#44; general purpose immunoglobulin will be administered even if they have been vaccinated&#46;</p></li><li class="elsevierStyleListItem" id="lsti0085"><span class="elsevierStyleLabel">-</span><p id="par0245" class="elsevierStylePara elsevierViewall">From 4 to 6 days after contact&#58; general purpose immunoglobulin will be administered to all susceptible and immunodepressed individuals&#44; even if they have been vaccinated&#46;</p></li></ul></p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Treatment</span><p id="par0250" class="elsevierStylePara elsevierViewall">The patient will continue in isolation&#44; preferentially in their own home&#44; although if their clinical situation makes it necessary they will be admitted to hospital in a negative pressure room&#46; If a vulnerable person has to enter the room&#44; as well as the standard safety measures they will have to take precautions to prevent airborne transmission while the disease is transmissible&#46;</p><p id="par0255" class="elsevierStylePara elsevierViewall">Treatment will be symptomatic and supportive&#44; as well as preventing possible bacterial complications&#46; Additionally&#44; vitamin A will be administered once a day during 2 days&#44; at the following doses&#58; 200&#44;000&#8201;UI for children over 12 months old&#44; 100&#44;000&#8201;UI in babies aged from 6 to 11 months old&#44; and 50&#44;000&#8201;UI for those under the age of 6 months old&#46; A third dose will be given from 2 to 4 weeks afterwards to children with clinical signs of vitamin A deficiency&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Vaccination</span><p id="par0260" class="elsevierStylePara elsevierViewall">The first vaccines were developed by Enders&#44; who together with Peebles isolated and cultivated the measles virus in 1954&#46; It originated in a student named Edmonston&#44; who gave its name to one of the most widely used vaccine strains of live attenuated virus&#46; The first vaccine was approved in the United States in 1963&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0265" class="elsevierStylePara elsevierViewall">Research was conducted into inactivated vaccines in the United States in the 1960s&#44; and in 1963 the first one derived from the Edmonston strain was authorised&#46; Al though this vaccine had fewer side effects&#44; it was also less effective&#44; and when a vaccinated individual subsequently came into contact with the wild virus they developed atypical measles&#46; This disease is caused by antigen-antibody immune complexes &#40;delayed reaction hypersensitivity&#41; &#40;see the <span class="elsevierStyleItalic">Clinical Forms</span> section&#41;&#44; so that it ceased to be used 4 years later&#46;<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8&#44;32</span></a></p><p id="par0270" class="elsevierStylePara elsevierViewall">Two attenuated Edmonston B strain vaccines were used in Barcelona in 2 pioneering clinical trials in Europe in 1961 and 1962&#46;<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">35</span></a> Given the high reactogenicity &#40;high fever and exanthema&#41; observed in the first clinical trial&#44; in the second one immunoglobulin was administered after vaccination in 3 groups&#44; on the same day and on the third and sixth days&#44; to reduce the side effects&#46;</p><p id="par0275" class="elsevierStylePara elsevierViewall">The first measles vaccination campaign in Spain commenced in 1968 in 11 provinces&#44; vaccinating children aged from 9 to 24 months old&#59; the vaccine used contained the Beckenham 31 strain&#44; which was found to be highly reactogenic&#46;<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">36</span></a> With this strain a severe reaction &#40;encephalitis&#41; was observed in England&#44; and it was withdrawn&#46; This contributed to the suspension of vaccination in Spain in 1970&#46;</p><p id="par0280" class="elsevierStylePara elsevierViewall">Parallel research took place into obtaining hyperattenuated strains&#44; one of which&#44; the Schwarz strain &#40;1964&#41;&#44; originated in the Edmonston A strain but was far less reactogenic&#46; This was used in the first monovalent anti-measles vaccine &#40;Rouvax&#174;&#41;&#44; which was utilised in the first systematic vaccination calendar in Spain by Barcelona Town Hall in 1973&#44; at 12 months of age&#46;<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a> This vaccine was included in Spain in the calendar drawn up by the Direcci&#243;n General de Sanidad in 1977&#44; for use at 9 months old&#46;<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">36</span></a> In comparison with the previous attenuated vaccine&#44; this hyperattenuated strain caused side effects less often and they were less severe&#44; making it possible to eliminate the use of immunoglobulin&#46;</p><p id="par0285" class="elsevierStylePara elsevierViewall">Two live hyperattenuated vaccines were authorised in 1965 and 1968&#46; These too were derived from the Edmonston strain&#44; and they contained the Schwarz and Moraten strains <span class="elsevierStyleItalic">&#40;MORe ATtenuated ENders&#41;</span>&#44; respectively&#46;</p><p id="par0290" class="elsevierStylePara elsevierViewall">The current attenuated live virus vaccine which is administered in the form of the triple viral vaccine is available in Spain in two forms&#44; one with the Schwarz strain and the other with the Enders&#8217; Edmonston strain&#46; This vaccine was included in the calendar of all of the autonomous communities in 1981&#44; and in the second dose in 1996&#44;<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a> although Catalonia had already done so in 1988&#46;<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">36</span></a> The vaccine must not be administered prior to the age of 12 months old&#44; except in situations of pre-exposure and post-exposure prophylaxis&#44; in which case it can be given after the age of 6 months &#40;although the technical data sheet states that it is for after the age of 9 months&#44; the medical authorities have authorised this&#41;&#46; When the vaccine is administered at 6-11 months it is indispensible to prescribe 2 further doses after the age of 12 months&#46;</p><p id="par0295" class="elsevierStylePara elsevierViewall">A dose administered at 12 months of age induces an immune response with seroconversion in more than 95&#37; of vaccinated individuals&#59; a second dose between 2 to 4 years old makes it possible to rescue nearly all of the others &#40;4&#46;5&#37;&#41;&#44; i&#46;e&#46;&#44; the initial failures&#46; After modification of the first strategy a second recall dose is administered after at least 4 weeks&#44; with the aim of rescuing those who have not responded&#46; The maximum response occurs at from 6-8 weeks after vaccination&#46; It has been found that vaccine-conferred immunity lasts for at least 20 years&#44; and it is believed that it lasts for the whole life of the majority of individuals&#46;<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7&#8211;9</span></a> The most frequent adverse reactions after vaccination are local&#44; although sometimes a case of attenuated measles may occur &#40;as described under the heading <span class="elsevierStyleItalic">Clinical forms</span>&#41;&#46;</p><p id="par0300" class="elsevierStylePara elsevierViewall">The protective efficacy of the measles vaccines in several studies was found to range from 93&#37; to 97&#37; after one and 2 doses&#44; respectively&#46;<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7&#8211;9</span></a> To achieve herd immunity a second dose vaccination coverage rate higher than 95&#37; is necessary&#46; Excellent vaccination was achieved in Spain in 2017 and 2018&#44; higher than 97&#37; for the first dose but only 93&#46;1&#37; and 94&#46;1&#37; for the second dose&#44; respectively&#59; moreover&#44; 9 autonomous communities were below 95&#37;&#44; and this aspect must be improved&#46;<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a></p><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Pre-exposure prophylaxis</span><p id="par0305" class="elsevierStylePara elsevierViewall">When a susceptible individual has to travel to a place where the measles virus is circulating&#44; the following action will be taken&#58;<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7&#44;8</span></a><ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0090"><span class="elsevierStyleLabel">-</span><p id="par0310" class="elsevierStylePara elsevierViewall">Babies under 6 months old&#58; if the mother is susceptible&#44; intramuscular general purpose immunoglobulin will be administered&#46;</p></li><li class="elsevierStyleListItem" id="lsti0095"><span class="elsevierStyleLabel">-</span><p id="par0315" class="elsevierStylePara elsevierViewall">Babies aged from 6 to 11 months&#58; a dose of triple viral vaccine will be administered and this will be considered to be dose 0&#46; At 12 months a 2 dose pattern will commence&#44; with an interval of at least 28 days&#46;</p></li><li class="elsevierStyleListItem" id="lsti0100"><span class="elsevierStyleLabel">-</span><p id="par0320" class="elsevierStylePara elsevierViewall">Children over the age of 12 months and adults&#58; it must be confirmed whether they have received the recommended 2 doses after the age of 12 months&#44; or if they have had the disease&#46; If the individual is susceptible they will be vaccinated with 2 triple viral vaccine doses separated by an interval of one month &#40;and if they had been vaccinated with a single dose&#44; they will be given a second dose&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0105"><span class="elsevierStyleLabel">-</span><p id="par0325" class="elsevierStylePara elsevierViewall">Susceptible children and adults for whom the vaccine is contraindicated &#40;those under the age of 6 months&#44; pregnant women and immunodepressed individuals&#44; including those who have been vaccinated&#41;&#58; general purpose intramuscular immunoglobulin at a dose of 0&#46;5&#8201;ml&#47;kg &#40;maximum dose&#58; 15&#8201;ml&#41;&#59; in high risk immunodepressed individuals this dose will be administered intravenously&#46;</p></li></ul></p></span></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Conclusions</span><p id="par0330" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0110"><span class="elsevierStyleLabel">-</span><p id="par0335" class="elsevierStylePara elsevierViewall">After the continuous fall in the morbidity and mortality caused by measles during this century&#44; from 2017 onwards a global resurgence of the disease has occurred due to a range of reasons&#46; This situation has arisen when progress was being made towards the eradication of the disease&#44; which had been foreseen to take place in this year&#44; 2020&#46; This resurgence has even occurred in Europe and in countries where measles had been eliminated&#44; and the primary cause is very worrying&#58; the fall in vaccination coverage due to reluctance to vaccinate&#46;</p></li><li class="elsevierStyleListItem" id="lsti0115"><span class="elsevierStyleLabel">-</span><p id="par0340" class="elsevierStylePara elsevierViewall">Doctors &#40;pedestrians and family doctors&#41; must suspect measles in any individual&#44; after anamnesis to evaluate their immunity status and possible contacts&#44; who has fever and catarrhal symptoms that have evolved over several days&#44; with the subsequent appearance of a generalised maculopapular exanthema&#46;</p></li><li class="elsevierStyleListItem" id="lsti0120"><span class="elsevierStyleLabel">-</span><p id="par0345" class="elsevierStylePara elsevierViewall">The epidemiological vigilance department is to be urgently informed when there is the suspicion of a case of measles&#44; determining its specific IgM and isolating the patient&#46;</p></li><li class="elsevierStyleListItem" id="lsti0125"><span class="elsevierStyleLabel">-</span><p id="par0350" class="elsevierStylePara elsevierViewall">If the suspected case is confirmed then an epidemiological survey will be performed and post-exposure prophylaxis will be administered to susceptible contacts&#46;</p></li><li class="elsevierStyleListItem" id="lsti0130"><span class="elsevierStyleLabel">-</span><p id="par0355" class="elsevierStylePara elsevierViewall">Systematic vaccination must take place infancy with the 2 dose triple viral vaccine after the age of 12 months&#44; with a check that vaccination has taken place in all age groups for susceptible individuals&#44; if vaccination is not contraindicated&#46; Pre-exposure prophylaxis by vaccination must take place over the age of 6 months&#46;</p></li><li class="elsevierStyleListItem" id="lsti0135"><span class="elsevierStyleLabel">-</span><p id="par0360" class="elsevierStylePara elsevierViewall">The great paradox is that vaccines save us from diseases and then lead us to forget the ones they saved us from&#46;</p></li></ul></p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Informed consent</span><p id="par0365" class="elsevierStylePara elsevierViewall">The author declares that he has the informed consent of all of the tutors of the patient for the publication of the clinical images in this paper&#44; and that their personal data have been protected&#44; according to the protocols of the institution&#46;</p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Conflict of interests</span><p id="par0370" class="elsevierStylePara elsevierViewall">The author has no conflict of interests to declare&#46; The author of this paper declares that he is a member of the Editorial Committee of the journal <span class="elsevierStyleItalic">Vacunas</span>&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:16 [
        0 => array:3 [
          "identificador" => "xres1510434"
          "titulo" => "Summary"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1370088"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres1510435"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1370089"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:3 [
          "identificador" => "sec1005"
          "titulo" => "Epidemiology"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Measles in the world"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Measles in Europe"
            ]
            2 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Measles in Spain"
            ]
          ]
        ]
        6 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Clinical manifestations"
        ]
        7 => array:2 [
          "identificador" => "sec0035"
          "titulo" => "Clinical forms"
        ]
        8 => array:2 [
          "identificador" => "sec0040"
          "titulo" => "Complications"
        ]
        9 => array:2 [
          "identificador" => "sec0045"
          "titulo" => "Diagnosis"
        ]
        10 => array:3 [
          "identificador" => "sec0050"
          "titulo" => "Actions&#44; preventive measures and treatment"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Post-exposure prophylaxis"
            ]
            1 => array:2 [
              "identificador" => "sec0060"
              "titulo" => "Treatment"
            ]
          ]
        ]
        11 => array:3 [
          "identificador" => "sec0065"
          "titulo" => "Vaccination"
          "secciones" => array:1 [
            0 => array:2 [
              "identificador" => "sec0070"
              "titulo" => "Pre-exposure prophylaxis"
            ]
          ]
        ]
        12 => array:2 [
          "identificador" => "sec0075"
          "titulo" => "Conclusions"
        ]
        13 => array:2 [
          "identificador" => "sec0080"
          "titulo" => "Informed consent"
        ]
        14 => array:2 [
          "identificador" => "sec0085"
          "titulo" => "Conflict of interests"
        ]
        15 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-03-04"
    "fechaAceptado" => "2020-04-14"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1370088"
          "palabras" => array:4 [
            0 => "Measle"
            1 => "Exantematic disease"
            2 => "Epidemiology"
            3 => "Measles vaccine"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1370089"
          "palabras" => array:4 [
            0 => "Sarampi&#243;n"
            1 => "Enfermedades exantem&#225;ticas"
            2 => "Epidemiolog&#237;a"
            3 => "Vacunas antisarampi&#243;n"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Summary"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar9005" class="elsevierStyleSimplePara elsevierViewall">After the continued decline in measles morbidity and mortality during this century&#44; since 2017 there has been&#44; for various reasons &#40;vaccination reticence is very important&#41;&#44; a re-emergence of the disease around the world&#44; when walking towards its eradication&#46; Clinicians should suspect measles to anyone susceptible to fever and a clinical flulike presentation of several days of evolution&#44; with the subsequent appearance of a generalized maculopapulous rash&#46; When a measles case is suspected&#44; epidemiological surveillance service shall be urgently declared&#44; the specific IgM shall be determined and the patient isolated&#46; If the case is confirmed&#44; an epidemiological survey and post-exposure prophylaxis of the susceptible contacts will be carried out&#46; Routine vaccination in childhood with a triple viral vaccine with two doses from 12 months and in all persons with any age is essential&#44; and vaccine coverage of 95&#37; or more in the population is essential&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar9010" class="elsevierStyleSimplePara elsevierViewall">Despu&#233;s de la disminuci&#243;n continuada de la morbilidad y la mortalidad del sarampi&#243;n durante este siglo&#44; desde 2017 se observa&#44; por diversas razones &#40;la reticencia vacunal es muy importante&#41;&#44; una reemergencia de la enfermedad en todo el mundo&#44; cuando se caminaba hacia su erradicaci&#243;n&#46; Los cl&#237;nicos deben sospechar el sarampi&#243;n ante cualquier persona susceptible que presente fiebre y un cuadro catarral de varios d&#237;as de evoluci&#243;n&#44; con la aparici&#243;n posterior de un exantema maculopapuloso generalizado&#46; Cuando se sospeche un caso de sarampi&#243;n se declarar&#225; de manera urgente al servicio de vigilancia epidemiol&#243;gica&#44; se determinar&#225; la IgM espec&#237;fica y se aislar&#225; al paciente&#46; Si el caso se confirma&#44; se realizar&#225;n una encuesta epidemiol&#243;gica y la profilaxis post-exposici&#243;n de los contactos susceptibles&#46; Es fundamental la vacunaci&#243;n sistem&#225;tica en la infancia con vacuna triple v&#237;rica con dos dosis a partir de los 12 meses y en todas las personas susceptibles de cualquier edad&#44; y es imprescindible mantener coberturas vacunales del 95&#37; o m&#225;s en la poblaci&#243;n&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Moraga-Llop FA&#46; Sarampi&#243;n&#46; Reemergencia en el camino de la erradicaci&#243;n&#46; Vacunas&#46; 2020&#46; <span class="elsevierStyleInterRef" id="intr0005" href="https://doi.org/10.1016/j.vacun.2020.04.001">https&#58;&#47;&#47;doi&#46;org&#47;10&#46;1016&#47;j&#46;vacun&#46;2020&#46;04&#46;001</span></p>"
      ]
    ]
    "multimedia" => array:2 [
      0 => array:8 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 870
            "Ancho" => 1499
            "Tamanyo" => 153680
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0005"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Measles&#46; A&#46; Koplik spots in the oral mucosa&#46; B&#46; Start of exanthema behind the ears&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "fig0010"
        "etiqueta" => "Fig&#46; 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 851
            "Ancho" => 1501
            "Tamanyo" => 129734
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0010"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Measles&#46; A&#46; Measles facies &#40;conjunctivitis&#44; rhinitis and stomatitis&#41;&#46; B&#46; Characteristic maculopapular exanthema&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:39 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Organizaci&#243;n Mundial de la Salud&#46; Erradicaci&#243;n mundial del sarampi&#243;n&#46; 63&#46;&#170; Asamblea&#44; 25 de marzo de 2010&#46; Disponible en&#58; http&#58;&#47;&#47;apps&#46;who&#46;int&#47;gb&#47;ebwha&#47;pdf&#95;files&#47;WHA63&#47;A63&#95;18-sp&#46;pdf&#46;"
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "World Health Organization&#46; New measles surveillance data from WHO&#46; Disponible en&#58; https&#58;&#47;&#47;www&#46;who&#46;int&#47;immunization&#47;newsroom&#47;new-measles-data-august-2019&#47;en&#47;&#46;"
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The fourth disease&#44; 1900-2000"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M&#46;E&#46; Weisse"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(00)03623-0"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet&#46;"
                        "fecha" => "2001"
                        "volumen" => "357"
                        "paginaInicial" => "299"
                        "paginaFinal" => "301"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11214144"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The clinical significance of measles&#58; a review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "RT Perry"
                            1 => "NA Halsey"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1086/377712"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Infect Dis&#46;"
                        "fecha" => "2004"
                        "volumen" => "189"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "S4"
                        "paginaFinal" => "16"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15106083"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Measles 50 years after use of measles vaccine"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "JL Goodson"
                            1 => "JF Seward"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Infect Dis Clin N Am"
                        "fecha" => "2015"
                        "volumen" => "29"
                        "paginaInicial" => "725"
                        "paginaFinal" => "743"
                        "itemHostRev" => array:3 [
                          "pii" => "S0210569114000138"
                          "estado" => "S300"
                          "issn" => "02105691"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Control of communicable diseases manual"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "D&#46;L&#46; Heymann"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:6 [
                        "edicion" => "20th ed&#46;"
                        "fecha" => "2015"
                        "paginaInicial" => "389"
                        "paginaFinal" => "397"
                        "editorial" => "American Public Health Association"
                        "editorialLocalizacion" => "Washington"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Measles"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "American Academy of Pediatrics"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:6 [
                        "editores" => "DWKimberlin, MTBrady, MTJackson, SSLong"
                        "titulo" => "Red Book&#58; 2018 Report of the Committee on Infectious Diseases"
                        "paginaInicial" => "537"
                        "paginaFinal" => "550"
                        "edicion" => "31st ed&#46;"
                        "serieFecha" => "2018"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Measles vaccines"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "P&#46;M&#46; Strebel"
                            1 => "M&#46;J&#46; Papania"
                            2 => "A&#46;P&#46; Fiebelkorn"
                            3 => "N&#46;A&#46; Halsey"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:6 [
                        "editores" => "SAPlotkin, WAOrenstein, POffit"
                        "titulo" => "Vaccines"
                        "paginaInicial" => "352"
                        "paginaFinal" => "387"
                        "edicion" => "6th ed&#46;"
                        "serieFecha" => "2013"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Measles"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "P&#46;M&#46; Strebel"
                            1 => "WA Orenstein"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMcp1905181"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2019"
                        "volumen" => "381"
                        "paginaInicial" => "349"
                        "paginaFinal" => "357"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31184814"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Measles antibody levels in young infants"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Science"
                            1 => "R&#46; Savage"
                            2 => "A&#46; Severini"
                            3 => "E&#46; McLachlan"
                            4 => "S&#46;L&#46; Hughes"
                            5 => "C&#46; Arnold"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1542/peds.2019-0630"
                      "Revista" => array:5 [
                        "tituloSerie" => "Pediatrics&#46;"
                        "fecha" => "2019"
                        "volumen" => "144"
                        "paginaInicial" => "e20190630"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31753911"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Immunogenicity&#44; effectiveness&#44; and safety of measles vaccination in infants younger than 9 months&#58; a systematic review and meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "L&#46;M&#46; Nic Lochlainn"
                            1 => "B&#46; de Gier"
                            2 => "N&#46; van der Maas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S1473-3099(19)30395-0"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet Infect Dis&#46;"
                        "fecha" => "2019"
                        "volumen" => "19"
                        "paginaInicial" => "1235"
                        "paginaFinal" => "1245"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31548079"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses&#58; a systematic review and meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "L&#46;M&#46; Nic Lochlainn"
                            1 => "B&#46; de Gier"
                            2 => "N&#46; van der Maas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S1473-3099(19)30396-2"
                      "Revista" => array:7 [
                        "tituloSerie" => "Lancet Infect Dis&#46;"
                        "fecha" => "2019"
                        "volumen" => "19"
                        "paginaInicial" => "1246"
                        "paginaFinal" => "1254"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31548081"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S1130239914000741"
                          "estado" => "S300"
                          "issn" => "11302399"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Measles vaccine immune escape&#58; should we be concerned&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "L&#46; Yang"
                            1 => "B&#46;T&#46; Grenfell"
                            2 => "M&#46;J&#46; Mina"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Eur J Epidemiology&#46;"
                        "fecha" => "2019"
                        "volumen" => "34"
                        "paginaInicial" => "893"
                        "paginaFinal" => "896"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Is the global measles resurgence a &#8220;public health emergency of international concern&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "D&#46;N&#46; Durrheim"
                            1 => "N&#46;S&#46; Crowcroft"
                            2 => "L&#46;H&#46; Blumberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ijid.2019.04.016"
                      "Revista" => array:7 [
                        "tituloSerie" => "Int J Infect Dis&#46;"
                        "fecha" => "2019"
                        "volumen" => "83"
                        "paginaInicial" => "95"
                        "paginaFinal" => "97"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31054965"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S1130239915000851"
                          "estado" => "S300"
                          "issn" => "11302399"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "World Health Organization&#46; Measles and rubella surveillance data&#46; Disponible en&#58; https&#58;&#47;&#47;www&#46;who&#46;int&#47;immunization&#47;monitoring&#95;surveillance&#47;burden&#47;vpd&#47;surveillance&#95;type&#47;active&#47;measles&#95;monthlydata&#47;en&#47;&#46;"
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Progress toward regional measles elimination &#8212; worldwide&#44; 2000&#8211;2018"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;K&#46; Patel"
                            1 => "L&#46; Dumolard"
                            2 => "Y&#46; Nedelec"
                            3 => "S&#46;V&#46; Sodha"
                            4 => "S&#46; Steulet"
                            5 => "M&#46; Gacic-Dobo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.15585/mmwr.mm6848a1"
                      "Revista" => array:7 [
                        "tituloSerie" => "MMWR Morb Mortal Wkly Rep&#46;"
                        "fecha" => "2019"
                        "volumen" => "68"
                        "paginaInicial" => "1105"
                        "paginaFinal" => "1111"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31805033"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S1130862117300098"
                          "estado" => "S300"
                          "issn" => "11308621"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Centers for Disease Control and Prevention &#40;CDC&#41;&#46; Measles cases and outbreaks&#46; Disponible en&#58; https&#58;&#47;&#47;www&#46;cdc&#46;gov&#47;measles&#47;cases-outbreaks&#46;html&#46;"
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Comit&#233; Asesor de Vacunas&#44; Asociaci&#243;n Espa&#241;ola de Pediatr&#237;a&#46; &#191;Qu&#233; ha pasado con el sarampi&#243;n en Samoa&#63; Disponible en&#58; https&#58;&#47;&#47;vacunasaep&#46;org&#47;profesionales&#47;noticias&#47;sarampion-en-samoa&#46;"
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "World Health Organization&#46; Over 100 000 people sick with measles in 14 months&#58; with measles cases at an alarming level in the European Region&#44; WHO scales up response&#46; Disponible en&#58; http&#58;&#47;&#47;www&#46;euro&#46;who&#46;int&#47;en&#47;media-centre&#47;sections&#47;press-releases&#47;2019&#47;over-100-000-people-sick-with-measles-in-14-months-with-measles-cases-at-an-alarming-level-in-the-european-region&#44;-who-scales-up-response&#46;"
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "World Health Organization&#46; European Region loses ground in effort to eliminate measles&#46; Disponible en&#58; http&#58;&#47;&#47;www&#46;euro&#46;who&#46;int&#47;en&#47;media-centre&#47;sections&#47;press-releases&#47;2019&#47;european-region-loses-ground-in-effort-to-eliminate-measles&#46;"
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:1 [
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:4 [
                        "titulo" => "Departament de Sanitat i Seguretat Social&#46; L&#8217;eliminaci&#243; del xarampi&#243; a Catalunya per a l&#8217;any 2000&#46; Bases cient&#237;fiques i programa"
                        "fecha" => "1999"
                        "editorial" => "Gr&#224;fiques Viking"
                        "editorialLocalizacion" => "Barcelona"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Comit&#233; Asesor de Vacunas&#44; Asociaci&#243;n Espa&#241;ola de Pediatr&#237;a&#46; Sarampi&#243;n en Espa&#241;a&#58; balance del a&#241;o 2019&#46; Disponible en https&#58;&#47;&#47;vacunasaep&#46;org&#47;profesionales&#47;noticias&#47;sarampion-espana-2019-balance-inicial&#46;"
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Plan de eliminaci&#243;n del sarampi&#243;n y rubeola&#46; Espa&#241;a"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:4 [
                            0 => "M&#46;V&#46; Torres de Mier"
                            1 => "L&#46; Reh"
                            2 => "N&#46; L&#243;pez-Perea"
                            3 => "J&#46; Masa Calles"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:1 [
                        "fecha" => "2017"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarampi&#243;n&#46; Rubeola&#46; Diagn&#243;stico diferencial de las enfermedades exantem&#225;ticas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M Casanova-Bellido"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:6 [
                        "editores" => "MCruz Hern&#225;ndez"
                        "titulo" => "Tratado de Pediatr&#237;a"
                        "paginaInicial" => "465"
                        "paginaFinal" => "474"
                        "edicion" => "10&#46;&#170; ed"
                        "serieFecha" => "2011"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Exantemas de origen infeccioso&#46; Diagn&#243;ostico diferencial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "F&#46;A&#46; Moraga-Llop"
                            1 => "A&#46; Mart&#237;nez-Roig"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:6 [
                        "editores" => "JJGarc&#237;a, OCruz, SMintegi, JMMoreno"
                        "titulo" => "M&#46; Cruz&#46; Manual de Pediatr&#237;a"
                        "paginaInicial" => "329"
                        "paginaFinal" => "334"
                        "edicion" => "4&#46;&#170; ed"
                        "serieFecha" => "2020"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Measles virus &#40;Rubeola&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "A&#46;A&#46; Gershon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:6 [
                        "editores" => "GLMandell, JEBennett, RDolin"
                        "titulo" => "Mandell&#44; Douglas&#44; and Bennett&#8217;s Principles and Practice of Infectious Diseases"
                        "paginaInicial" => "2031"
                        "paginaFinal" => "2038"
                        "edicion" => "6th ed&#46;"
                        "serieFecha" => "2005"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "El xarampi&#243;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "FA Moraga Llop"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Pediatr Catalana&#46;"
                        "fecha" => "1999"
                        "volumen" => "59"
                        "paginaInicial" => "5"
                        "paginaFinal" => "53"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Measles"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "W&#46;J&#46; Moss"
                            1 => "DE Griffin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(10)62352-5"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2012"
                        "volumen" => "379"
                        "paginaInicial" => "153"
                        "paginaFinal" => "164"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21855993"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "V&#46;N&#46; Petrova"
                            1 => "B&#46; Sawatsky"
                            2 => "A&#46;X&#46; Han"
                            3 => "B&#46;M&#46; Laksono"
                            4 => "L&#46; Walz"
                            5 => "E&#46; Parker"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Sci Immunol&#46;"
                        "fecha" => "2019"
                        "volumen" => "4"
                        "numero" => "41"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:5 [
                            0 => "M&#46;J&#46; Mina"
                            1 => "T&#46; Kula"
                            2 => "Y&#46; Leng"
                            3 => "M&#46; Li"
                            4 => "R&#46;D&#46; de Vries"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1126/science.aay6485"
                      "Revista" => array:6 [
                        "tituloSerie" => "Science&#46;"
                        "fecha" => "2019"
                        "volumen" => "366"
                        "paginaInicial" => "599"
                        "paginaFinal" => "606"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31672891"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarampi&#243;n"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "JM Sala Ginabreda"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:5 [
                        "editores" => "JMSala Ginabreda"
                        "titulo" => "Tratado de las enfermedades infecciosas en la infancia"
                        "paginaInicial" => "69"
                        "paginaFinal" => "102"
                        "serieFecha" => "1955"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Atypical measles syndrome&#58; pathologic and serologic findings"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46; Annunziato"
                            1 => "M&#46;H&#46; Kaplan"
                            2 => "W&#46;W&#46; Hall"
                            3 => "H&#46; Ichinose"
                            4 => "J&#46;H&#46; Lin"
                            5 => "D&#46; Balsam"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatrics&#46;"
                        "fecha" => "1982"
                        "volumen" => "70"
                        "paginaInicial" => "203"
                        "paginaFinal" => "209"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7099785"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Moffet&#8217;s Pediatric Infectious Diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46;G&#46; Fisher"
                            1 => "T&#46;G&#46; Boyce"
                            2 => "AG Correa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:6 [
                        "edicion" => "5th ed&#46;"
                        "fecha" => "2017"
                        "paginaInicial" => "321"
                        "paginaFinal" => "360"
                        "editorial" => "Wolters Kluwer"
                        "editorialLocalizacion" => "Philadelphia"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Sub-direcci&#243; General de Vigil&#224;ncia i Resposta a Emerg&#232;ncies de Salut P&#250;blica&#46; Protocol d&#8217;actuaci&#243; per a la prevenci&#243; i el control del xarampi&#243;&#46; Barcelona&#58; Ag&#232;ncia de Salut P&#250;blica de Catalunya&#46; Departament de Salut&#59; agost de 2019&#46; Disponible en&#58; http&#58;&#47;&#47;canalsalut&#46;gencat&#46;cat&#47;web&#47;&#46;content&#47;AZ&#47;X&#47;xarampio&#47;arxius&#47;protocol&#95;xarampio&#46;pdf&#46;"
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ensayos de la vacuna antisarampionosa de virus vivo atenuado"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M&#46; Carbonell Juanico"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Bol Soc Cat Pediatr&#46;"
                        "fecha" => "1971"
                        "volumen" => "152"
                        "paginaInicial" => "31"
                        "paginaFinal" => "42"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Programa y coberturas de vacunaci&#243;n frente a sarampi&#243;n y rubeola en Espa&#241;a&#46; Retos para alcanzar su eliminaci&#243;n"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46; Limia S&#225;nchez"
                            1 => "M&#46; Molina Olivas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4321/S1135-57272015000400004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Esp Salud P&#250;blica&#46;"
                        "fecha" => "2015"
                        "volumen" => "89"
                        "paginaInicial" => "357"
                        "paginaFinal" => "364"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26580791"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Establecimiento del calendario de vacunaciones"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46; Prandi Farr&#224;s"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Bol Soc Cat Pediatr&#46;"
                        "fecha" => "1974"
                        "volumen" => "168"
                        "paginaInicial" => "100"
                        "paginaFinal" => "105"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "El retraso en la eliminaci&#243;n del sarampi&#243;n en Europa&#58; razones&#44; obst&#225;culos y perspectivas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46; Masa-Calles"
                            1 => "N&#46; L&#243;pez-Perea"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Bol Epidemiol Sem&#46;"
                        "fecha" => "2019"
                        "volumen" => "27"
                        "paginaInicial" => "63"
                        "paginaFinal" => "69"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "39"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Novedades en vacunolog&#237;a 2018-2019"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46;A&#46; Moraga-Llop"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:5 [
                        "editores" => "MCampins Mart&#237;, FAMoraga Llop"
                        "titulo" => "Vacunas 2019"
                        "paginaInicial" => "173"
                        "paginaFinal" => "190"
                        "serieFecha" => "2019"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/24451460/0000002100000001/v4_202105130819/S244514602030008X/v4_202105130819/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "85161"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Review Articles"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/24451460/0000002100000001/v4_202105130819/S244514602030008X/v4_202105130819/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S244514602030008X?idApp=UINPBA00004N"
]
Article information
ISSN: 24451460
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2023 March 2 0 2

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos